How to Buy Sangamo Therapeutics Stock
Sangamo Therapeutics Inc
Sangamo Therapeutics, Inc. , a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation.
Sangamo Therapeutics stock last closed at $0.74, down 5.97% from the previous day, and has increased 41.76% in one year. It has overperformed other stocks in the Biotechnology industry by 1.19 percentage points. Sangamo Therapeutics stock is currently +143.42% from its 52-week low of $0.30, and -76.72% from its 52-week high of $3.18.
At the moment, there are 224.71M shares of SGMO outstanding. The market cap of SGMO is $166.29M. In the last 24 hours, 3.85M SGMO shares were traded.
How to Buy Sangamo Therapeutics Stock
Not sure how to invest in Sangamo Therapeutics stock? Here's how.
- Figure out where to buy Sangamo Therapeutics stock: You need to decide on an online brokerage, but don't worry - we've researched dozens of online brokerages and apps to help you choose where to buy Sangamo Therapeutics stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit money your investment account: Select your payment method and add your information.
- Research Sangamo Therapeutics stock: The Sangamo Therapeutics ticker symbol is SGMO. Is Sangamo Therapeutics stock a good investment? Should you buy shares of SGMO? How do SGMO's underlying business fundamentals look? Do top analysts think Sangamo Therapeutics is a good buy? Why has SGMO's stock price moved recently? (Hint: Our stock research tools can help you decide if SGMO is a good stock to buy).
- Make your SGMO buy order: Decide if you will purchase SGMO shares at the current market price or use a limit order to buy SGMO shares at a particular price.
- Get key alerts regarding your SGMO position: Create a watchlist to important notifications about your position in Sangamo Therapeutics shares.
Step 1: Figure out where to buy Sangamo Therapeutics stock
You need an online brokerage account to access the NASDAQ market and buy SGMO shares.
Our recommended brokerage: eToro
Based on our research, eToro is the best place to buy stocks. eToro gives you:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to global markets: From Technology to Healthcare, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've chosen the best brokerage, you'll need to fill out some personal info so you can invest in SGMO today.
How to Open a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to create a new brokerage account.
- Submit your information by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you've finished signing up on stock market apps, your next step is to transfer the money for your investment:
Check out the video below for more details transferring money into your brokerage account.
Step 4: Research Sangamo Therapeutics stock
After you have selected the best place to buy Sangamo Therapeutics stock, it's crucial to research their stock before you buy, so you actually understand the risk and upside.
Sangamo Therapeutics shares at a glance
Sangamo Therapeutics Fundamentals
WallStreetZen was built to help everyday investors do more accurate fundamental analysis in less time.
You can view all of the due diligence checks on SGMO's stock page.
Is SGMO stock undervalued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge SGMO's intrinsic value.
Using relative valuations methods:
- SGMO could be overvalued based on its P/B ratio of 7.3x, relative to Biotechnology industry P/B ratio of 4.32x
You can access more valuation research on SGMO's stock here.
SGMO Financial Health Overview
Passed Health Checks:
- There are more short-term assets than short-term liabilities on the SGMO balance sheet.
- There are more short-term assets than long-term liabilities on the SGMO balance sheet.
- SGMO has $43.42M in cash and short term investments. This is sufficient to cover its annual cash burn of $67.41M.
Failed Health Checks:
- Total SGMO debt is higher than 5 years ago, relative to shareholder equity.
- SGMO profit margin has gone down from -146.3% to -169.4% in the past year.
- SGMO has cash burn of 67406000. It does not have enough cash and short-term investments to cover this.
- SGMO has a relatively high debt to equity ratio of 3.46.
Is it a good time to buy SGMO stock, according to Wall Street analysts?
Out of 6 Equities analysts who give ratings on SGMO, the consensus analyst rating on SGMO is a Buy
Please note that analyst forecasts are not stock recommendations, nor are they financial advice.
Most Recent SGMO Analyst Upgrades/Downgrades
Gena Wang, a bottom 5% analyst from Barclays maintains SGMO with a strong buy rating and raises their SGMO price target from $3.00 to $9.00, on Nov 14, 2024.
You can dig deeper into what analysts are saying on the Sangamo Therapeutics stock forecast page.
SGMO Technicals
SGMO Performance Metrics
Last year, SGMO revenue was $57.80M. Over the last five year, SGMO's revenue has grown by -10.81% per year. This was slower than the Biotechnology industry average of 45.91%.
Find out more about SGMO's earnings and revenue performance here.
What are SGMO insiders up to?
Over the past year, executives and large shareholders at SGMO have sold more shares than they have bought.
Gregory D. Davis, Head of Research Technology of SGMO, was the latest SGMO insider to sell. They sold $5,205.41 worth of SGMO stock on Apr 22, 2025.
Learn more about who owns SGMO shares here.
Can I rely on SGMO as an income stream?
No, Sangamo Therapeutics doesn't provide an income stream by paying out dividends.
What do other traders have to say about SGMO?
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Make your SGMO buy order
There are two primary order types:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are generally the best for newer investors. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a given dollar amount limit, use a limit order.
Hit the Open Trade button and eToro will place the order.
If you want additional info about investing in stocks on eToro, watch the helpful video below:
Step 6: Get key alerts regarding your SGMO position
Now that you own some SGMO stock, you'll want to stay up-to-date on your investment.
Create a watchlist to keep tabs on your SGMO stock.
SGMO Feed
How to Buy Stock in Sangamo Therapeutics
To summarize, here are the 6 steps for buying Sangamo Therapeutics stock:
- Figure out where to buy Sangamo Therapeutics stock
- Open a brokerage account
- Deposit money your investment account
- Research Sangamo Therapeutics stock
- Make your SGMO buy order
- Get key alerts regarding your SGMO position
If you are looking for a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you want to get notifications regarding your investment in Sangamo Therapeutics, click the button below.
Related Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.